Skip to main content
SpringerLink
Log in

READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure—a systematic review and network meta-analysis of randomised trials

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

The majority of patients with chronic heart failure (HF) receive long-term treatment with loop diuretics. The comparative effectiveness of different loop diuretics is unknown. We searched PubMed, clinicaltrials.gov, the Cochrane Central Register of Controlled Trials and the European Union Clinical Trials Register for randomised clinical trials exploring the efficacy of the loop diuretics azosemide, bumetanide, furosemide or torasemide in patients with HF. Comparators included placebo, standard medical care or any other active treatment. The primary endpoint was all-cause mortality. Secondary endpoints included cardiovascular mortality, HF-related hospitalisation and any combined endpoint thereof. Hypokalaemia and acute renal failure were defined as additional safety endpoints. Evidence was synthesised using network meta-analysis (NMA). Thirty-four trials reporting on 2647 patients were included. The overall quality of evidence was rated as moderate. NMA demonstrated no significant differences between loop diuretics with respect to all-cause mortality, cardiovascular mortality or hypokalaemia. In contrast, torasemide ranked best in terms of HF hospitalisation, and there was a trend towards benefits with torasemide with regard to occurrence of acute renal failure. Sensitivity analyses excluding trials with a follow-up < 6 months, trials with a cross-over design and those including < 25 patients confirmed the main results. We found no significant superiority of either loop diuretic with respect to mortality and safety endpoints. However, clinicians may prefer torasemide, as it was associated with fewer HF-related hospitalisations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216

    Article  PubMed  Google Scholar 

  2. Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27:1431–1439

    Article  PubMed  PubMed Central  Google Scholar 

  3. Allman S, Norris RJ (1990) An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. J Int Med Res 18(Suppl 2):17b–23b

    PubMed  Google Scholar 

  4. Asami M, Aoki J, Tanimoto S, Horiuchi Y, Watanabe M, Furui K, Yasuhara K, Sato T, Tanabe K, Hara K (2017) Effects of long-acting loop diuretics in heart failure with reduced ejection fraction patients with cardiac resynchronization therapy. Int Heart J 58:211–219

    Article  CAS  PubMed  Google Scholar 

  5. Bikdeli B, Strait KM, Dharmarajan K, Partovian C, Coca SG, Kim N, Li SX, Testani JM, Khan U, Krumholz HM (2013) Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives? J Am Coll Cardiol 61:1549–1550

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bleske BE, Welage LS, Kramer WG, Nicklas JM (1998) Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure. J Clin Pharmacol 38:708–714

    Article  CAS  PubMed  Google Scholar 

  7. Buggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ, O'Connor CM (2015) A reappraisal of loop diuretic choice in heart failure patients. Am Heart J 169:323–333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chaimani A, Higgins JP, Mavridis D et al (2013) Graphical tools for network meta-analysis in STATA. PLoS One 8:e76654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chaudhury RR, Chugh KS, Gupta GS et al (1968) A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide. J Assoc Physicians India 16:157–163

    CAS  PubMed  Google Scholar 

  10. Cody RJ, Franklin KW, Laragh JH (1982) Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure. Am Heart J 103:480–484

    Article  CAS  PubMed  Google Scholar 

  11. Cosin J, Diez J, Investigators T (2002) Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 4:507–513

    Article  CAS  PubMed  Google Scholar 

  12. Crawford RJ, Allman S, Gibson W, Kitchen S, Richards HH (1988) A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice. J Int Med Res 16:143–149

    Article  CAS  PubMed  Google Scholar 

  13. Damman K, Kjekshus J, Wikstrand J, Cleland JGF, Komajda M, Wedel H, Waagstein F, McMurray JJV (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Eur J Heart Fail 18:328–336

    Article  PubMed  Google Scholar 

  14. Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L, Genta FT, Cicoira M, Tavazzi L, Temporelli PL (2013) Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract 67:656–664

    Article  CAS  PubMed  Google Scholar 

  15. Dinicolantonio JJ (2012) Should torsemide be the loop diuretic of choice in systolic heart failure? Futur Cardiol 8:707–728

    Article  CAS  Google Scholar 

  16. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E, Studies of Left Ventricular Dysfunction (2003) Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42:705–708

    Article  CAS  PubMed  Google Scholar 

  17. Faris RF, Flather M, Purcell H et al (2012) Diuretics for heart failure. Cochrane Database Syst Rev:CD003838

  18. Ferrara N, Leosco D, Del P et al (1997) Torasemide versus furosemide in patients with congestive heart failure: a double-masked, randomized study. Curr Ther Res Clin Exp:291–299

  19. Funke Kupper AJ, Fintelman H, Huige MC et al (1986) Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure. Eur J Clin Pharmacol 30:341–343

    Article  CAS  PubMed  Google Scholar 

  20. Gabriel R, Baylor P (1981) Comparison of the chronic effects of bendrofluazide, bumetanide and frusemide on plasma biochemical variables. Postgrad Med J 57:71–74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Goebel KM (1993) Six-week study of torsemide in patients with congestive heart failure. Clin Ther 15:1051–1059

    CAS  PubMed  Google Scholar 

  22. Group. TTI (2011) Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clin Ther 33:1204–1213.e1203

    Article  CAS  Google Scholar 

  23. Gupta S, Waywell C, Gandhi N, Clayton N, Keevil B, Clark AL, Ng LL, Brooks N, Neyses L (2010) The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. Eur J Heart Fail 12:746–752

    Article  CAS  PubMed  Google Scholar 

  24. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 25:1154–1161

    Article  CAS  PubMed  Google Scholar 

  25. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, The JCARE-CARD Investigators (2012) Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 76:1920–1927

    Article  PubMed  Google Scholar 

  26. Han LN, Guo SL, Lin XM, Shi XM, Zang CB, Yang LM, Ding GL (2014) Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure. Genet Mol Res 13:7262–7274

    Article  CAS  PubMed  Google Scholar 

  27. Harada K, Izawa H, Nishizawa T, Hirashiki A, Murase Y, Kobayashi M, Isobe S, Cheng XW, Noda A, Nagata K, Yokota M, Murohara T (2009) Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide. J Cardiovasc Pharmacol 53:468–473

    Article  CAS  PubMed  Google Scholar 

  28. Higgins J, Green S, (Editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. In:The Cochrane Collaboration, 2011

  29. Higgins JP, Jackson D, Barrett JK et al (2012) Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 3:98–110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hisatake S, Nanjo S, Fujimoto S, Yamashina S, Yuzawa H, Namiki A, Nakano H, Yamazaki J (2011) Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy. Eur J Heart Fail 13:892–898

    Article  CAS  PubMed  Google Scholar 

  31. Hussain M, Walton K, Davidson C, Morgan DB (1985) A study of two diuretic/potassium combinations in heart failure. Postgrad Med J 61:29–33

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hutton B, Catala-Lopez F, Moher D (2016) The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA. Med Clin 147:262–266

    Article  Google Scholar 

  33. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G (2014) Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health 17:157–173

    Article  PubMed  Google Scholar 

  34. Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M (2006) Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. Heart 92:1434–1440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, van Gilst W, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology (2003) The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464–474

    Article  CAS  PubMed  Google Scholar 

  36. Konecke LL (1981) Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. J Clin Pharmacol 21:688–690

    Article  CAS  PubMed  Google Scholar 

  37. Kremer D (1983) Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 103:1165–1168

    CAS  Google Scholar 

  38. Levy B (1977) The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure. J Clin Pharmacol 17:420–430

    Article  CAS  PubMed  Google Scholar 

  39. Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6:8–14

    Article  PubMed  Google Scholar 

  40. Lopez B, Querejeta R, Gonzalez A et al (2004) Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43:2028–2035

    Article  CAS  PubMed  Google Scholar 

  41. Lopez B, Gonzalez A, Beaumont J et al (2007) Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 50:859–867

    Article  CAS  PubMed  Google Scholar 

  42. Mareev V, Mareev Y, Vygodin V et al (2017) Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial. In: European journal of heart failure. Conference: heart failure 2016 and the 3rd world congress on acute heart failure. Florence Italy. Conference start: 20160521. Conference end: 20160524. Conference publication: (var.pagings). P 382-383

  43. Masuyama T, Tsujino T, Origasa H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Ito H (2012) Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J 76:833–842

    Article  CAS  PubMed  Google Scholar 

  44. Matsuo Y, Kasama S, Toyama T, Funada R, Takama N, Koitabashi N, Ichikawa S, Suzuki Y, Matsumoto N, Sato Y, Kurabayashi M (2016) Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure. Open Heart 3:e000276

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mauersberger H, Rangoonwala B, Ehrlich E (1985) Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure. Wien Med Wochenschr (1946) 135:205–213

    CAS  Google Scholar 

  46. Mentz RJ, Velazquez EJ, Metra M, McKendry C, Chiswell K, Fiuzat M, Givertz MM, Voors AA, Teerlink JR, O'Connor CM (2015) Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Futur Cardiol 11:585–595

    Article  CAS  Google Scholar 

  47. Mentz RJ, Hasselblad V, Devore AD et al (2016) Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial). Am J Cardiol 117:404–411

    Article  CAS  PubMed  Google Scholar 

  48. Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y, Kusumoto A, Hamasaki S, Tei C, COLD-CHF Investigators (2012) Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). J Cardiol 59:352–358

    Article  PubMed  Google Scholar 

  49. Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1

    Article  PubMed  PubMed Central  Google Scholar 

  50. Moher D, Stewart L, Shekelle P (2016) Implementing PRISMA-P: recommendations for prospective authors. Syst Rev 5:15

    Article  PubMed  PubMed Central  Google Scholar 

  51. Muller K, Gamba G, Jaquet F et al (2003) Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. Eur J Heart Fail 5:793–801

    Article  CAS  PubMed  Google Scholar 

  52. Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams LD, Tierney WM, Brater DC (2001) Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111:513–520

    Article  CAS  PubMed  Google Scholar 

  53. Noe LL, Vreeland MG, Pezzella SM, Trotter JP (1999) A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 21:854–866

    Article  CAS  PubMed  Google Scholar 

  54. Ogino K, Kinugasa Y, Kato M, Yamamoto K, Hisatome I, Anker SD, Doehner W (2014) Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure. Int J Cardiol 171:398–403

    Article  PubMed  Google Scholar 

  55. Packer M, Medina N, Yushak M, Meller J (1983) Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation 68:803–812

    Article  CAS  PubMed  Google Scholar 

  56. Packer M, Lee WH, Medina N, Yushak M, Kessler PD (1987) Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 106:346–354

    Article  CAS  PubMed  Google Scholar 

  57. Parker JO (1993) The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. Int J Cardiol 40:221–227

    Article  CAS  PubMed  Google Scholar 

  58. Pehrsson SK (1985) Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. Eur J Clin Pharmacol 28:235–239

    Article  CAS  PubMed  Google Scholar 

  59. Pellicori P, Cleland JG, Zhang J et al (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovasc Drugs Ther 30:599–609

    Article  CAS  PubMed  Google Scholar 

  60. Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709–717

    Article  CAS  PubMed  Google Scholar 

  61. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200

    Article  PubMed  Google Scholar 

  62. Puhan MA, Schunemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, Kessels AG, Guyatt GH, for the GRADE Working Group (2014) A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ 349:g5630

    Article  Google Scholar 

  63. Ramsay F, Crawford RJ, Allman S, Bailey R, Martin A (1988) An open comparative study of two diuretic combinations, frusemide/amiloride (‘Frumil’) and bumetanide/potassium chloride (‘Burinex’ K), in the treatment of congestive cardiac failure in hospital out-patients. Curr Med Res Opin 10:682–689

    Article  CAS  PubMed  Google Scholar 

  64. Salanti G (2012) Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods 3:80–97

    Article  PubMed  Google Scholar 

  65. Salanti G, Marinho V, Higgins JP (2009) A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol 62:857–864

    Article  PubMed  Google Scholar 

  66. Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163–171

    Article  PubMed  Google Scholar 

  67. Salanti G, Del Giovane C, Chaimani A et al (2014) Evaluating the quality of evidence from a network meta-analysis. PLoS One 9:e99682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Sargento L, Simoes AV, Longo S et al (2016) Furosemide prescription during the dry state is a predictor of long-term survival of stable, optimally medicated patients with systolic heart failure. J Cardiovasc Pharmacol Ther

  69. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, the PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647

    Article  Google Scholar 

  70. Sharpe N, Murphy J, Smith H et al (1988) Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (London, England) 1:255–259

    Article  CAS  Google Scholar 

  71. Stewart JH, Edwards KD (1965) Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid. Br Med J 2:1277–1281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Torafic Investigators Group (2011) Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clin Ther 33(1204–1213):e1203

    Google Scholar 

  73. Tsutamoto T, Sakai H, Wada A, Ishikawa C, Ohno K, Fujii M, Yamamoto T, Takayama T, Dohke T, Horie M (2004) Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 44:2252–2253

    Article  CAS  PubMed  Google Scholar 

  74. Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M (1991) Anti-aldosteronergic effect of torasemide. Eur J Pharmacol 205:145–150

    Article  CAS  PubMed  Google Scholar 

  75. Van Kraaij DJ, Jansen RW, Bouwels LH et al (1999) Furosemide withdrawal improves postprandial hypotension in elderly patients with heart failure and preserved left ventricular systolic function. Arch Intern Med 159:1599–1605

    Article  PubMed  Google Scholar 

  76. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC (1995) Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57:601–609

    Article  CAS  PubMed  Google Scholar 

  77. Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K’, Suzuki K, Kodama M, Aizawa Y (2008) Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Eur J Pharmacol 581:121–131

    Article  CAS  PubMed  Google Scholar 

  78. Veeraveedu PT, Watanabe K, Ma M, Thandavarayan RA, Palaniyandi SS, Yamaguchi K’, Suzuki K, Kodama M, Aizawa Y (2008) Comparative effects of torasemide and furosemide in rats with heart failure. Biochem Pharmacol 75:649–659

    Article  CAS  PubMed  Google Scholar 

  79. Vermeulen A, Chadha DR (1982) Slow-release furosemide and hydrochlorothiazide in congestive cardiac failure: a controlled trial. J Clin Pharmacol 22:513–519

    Article  CAS  PubMed  Google Scholar 

  80. Watanabe K, Sreedhar R, Thandavarayan RA et al (2016) Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy. Biofactors

  81. Westheim AS, Bostrom P, Christensen CC et al (1999) Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. J Am Coll Cardiol 34:1794–1801

    Article  CAS  PubMed  Google Scholar 

  82. Wilson JR, Reichek N, Dunkman WB, Goldberg S (1981) Effect of diuresis on the performance of the failing left ventricle in man. Am J Med 70:234–239

    Article  CAS  PubMed  Google Scholar 

  83. Yamato M, Sasaki T, Honda K, Fukuda M, Akutagawa O, Okamoto M, Hayashi T (2003) Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ J 67:384–390

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Angiology, and Pulmonology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany

    Tobias Täger, Hanna Fröhlich, Mirjam Seiz, Hugo A. Katus & Lutz Frankenstein

Authors
  1. Tobias Täger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanna Fröhlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mirjam Seiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hugo A. Katus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lutz Frankenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lutz Frankenstein.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Disclosure

Tobias Täger has nothing to disclose. Hanna Fröhlich has nothing to disclose. Mirjam Seiz has nothing to disclose. H.A. Katus has nothing to disclose. L. Frankenstein has nothing to disclose.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 309 kb)

ESM 2

(PDF 433 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Täger, T., Fröhlich, H., Seiz, M. et al. READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure—a systematic review and network meta-analysis of randomised trials. Heart Fail Rev 24, 461–472 (2019). https://doi.org/10.1007/s10741-019-09771-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-019-09771-8

Keywords

Search

Navigation